UK Health Law and Global Bioethics Standards Post-Brexit

The Case of Pharmaceuticals and Medical Devices How can post-Brexit UK become (more of) a 'maker' rather than a 'taker' of global norms and standards or regulation? This paper focuses on the example of the global standards that apply to pharmaceuticals and medical devices. By reference to these examples, the paper underlines the importance of global standard setting and the necessity of UK engagement post-Brexit. Brexit will ensure the UK is no longer represented in global standard setting in respect of pharmaceuticals and medical devices as part of the EU's delegation. The UK will therefore have to become a member of the relevant global standard setting organisations in its own right. That is provided the UK wants to have a voice and play a role in crafting the standards with which it will have to comply anyway. Subsequently the paper charts a path towards maximising UK participation in global standard setting organisations and in the crafting of the global standards that will continue to apply to the UK (and in the EU and other key markets) post-Brexit.